Visco-Circumferential-Suture-Trabeculotomy Versus Trabeculotomy
Surgical Outcomes of Visco-Circumferential-Suture-Trabeculotomy in Primary Congenital Glaucoma: A 3-year Randomized Controlled Study
1 other identifier
interventional
51
1 country
1
Brief Summary
comparing outcomes of Visco-Circumferential-Suture-Trabeculotomy in primary congenital glaucoma to trabeculotomy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
December 19, 2020
CompletedFirst Posted
Study publicly available on registry
December 24, 2020
CompletedDecember 29, 2020
December 1, 2020
2.1 years
December 19, 2020
December 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
IOP
intraocular pressure measuring
36 months
Secondary Outcomes (1)
complications
36 months months
Study Arms (2)
Visco-Circumferential-Suture-Trabeculotomy
EXPERIMENTALVisco-Circumferential-Suture-Trabeculotomy
viscotrabeculotomy
ACTIVE COMPARATORViscotrabeculotomy
Interventions
performing partial unroofing of the SC and viscoelastic injection into the 2 ostia of the canal. This was followed by connecting the scalemm canal to the anterior chamber
Eligibility Criteria
You may qualify if:
- infants below the age of 2 years with PCG
You may not qualify if:
- patients older than 2 years on presentation
- eyes with previous surgery
- eyes with secondary glaucoma
- eyes diagnosed as anterior segment dysgenesis syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ophthalmic Center
Al Mansurah, 35516, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2020
First Posted
December 24, 2020
Study Start
January 1, 2015
Primary Completion
February 1, 2017
Study Completion
September 1, 2020
Last Updated
December 29, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share